These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28316055)

  • 21. Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects.
    Hua X; Lee S; Yanovsky I; Leow AD; Chou YY; Ho AJ; Gutman B; Toga AW; Jack CR; Bernstein MA; Reiman EM; Harvey DJ; Kornak J; Schuff N; Alexander GE; Weiner MW; Thompson PM;
    Neuroimage; 2009 Dec; 48(4):668-81. PubMed ID: 19615450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical applicability of quantitative atrophy measures on MRI in patients suspected of Alzheimer's disease.
    Ingala S; van Maurik IS; Altomare D; Wurm R; Dicks E; van Schijndel RA; Zwan M; Bouwman F; Schoonenboom N; Boelaarts L; Roks G; van Marum R; van Harten B; van Uden I; Claus J; Wottschel V; Vrenken H; Wattjes MP; van der Flier WM; Barkhof F
    Eur Radiol; 2022 Nov; 32(11):7789-7799. PubMed ID: 35639148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DeepAtrophy: Teaching a neural network to detect progressive changes in longitudinal MRI of the hippocampal region in Alzheimer's disease.
    Dong M; Xie L; Das SR; Wang J; Wisse LEM; deFlores R; Wolk DA; Yushkevich PA;
    Neuroimage; 2021 Nov; 243():118514. PubMed ID: 34450261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Training labels for hippocampal segmentation based on the EADC-ADNI harmonized hippocampal protocol.
    Boccardi M; Bocchetta M; Morency FC; Collins DL; Nishikawa M; Ganzola R; Grothe MJ; Wolf D; Redolfi A; Pievani M; Antelmi L; Fellgiebel A; Matsuda H; Teipel S; Duchesne S; Jack CR; Frisoni GB;
    Alzheimers Dement; 2015 Feb; 11(2):175-83. PubMed ID: 25616957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease.
    Leung KK; Barnes J; Ridgway GR; Bartlett JW; Clarkson MJ; Macdonald K; Schuff N; Fox NC; Ourselin S;
    Neuroimage; 2010 Jul; 51(4):1345-59. PubMed ID: 20230901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hippocampal volume change measurement: quantitative assessment of the reproducibility of expert manual outlining and the automated methods FreeSurfer and FIRST.
    Mulder ER; de Jong RA; Knol DL; van Schijndel RA; Cover KS; Visser PJ; Barkhof F; Vrenken H;
    Neuroimage; 2014 May; 92():169-81. PubMed ID: 24521851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns of hippocampal atrophy differ among Alzheimer's disease, amnestic mild cognitive impairment, and late-life depression.
    Joko T; Washizuka S; Sasayama D; Inuzuka S; Ogihara T; Yasaki T; Hagiwara T; Sugiyama N; Takahashi T; Kaneko T; Hanihara T; Amano N
    Psychogeriatrics; 2016 Nov; 16(6):355-361. PubMed ID: 26756596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study.
    Ridha BH; Barnes J; Bartlett JW; Godbolt A; Pepple T; Rossor MN; Fox NC
    Lancet Neurol; 2006 Oct; 5(10):828-34. PubMed ID: 16987729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Italian Alzheimer's Disease Neuroimaging Initiative (I-ADNI): validation of structural MR imaging.
    Cavedo E; Redolfi A; Angeloni F; Babiloni C; Lizio R; Chiapparini L; Bruzzone MG; Aquino D; Sabatini U; Alesiani M; Cherubini A; Salvatore E; Soricelli A; Vernieri F; Scrascia F; Sinforiani E; Chiarati P; Bastianello S; Montella P; Corbo D; Tedeschi G; Marino S; Baglieri A; De Salvo S; Carducci F; Quattrocchi CC; Cobelli M; Frisoni GB
    J Alzheimers Dis; 2014; 40(4):941-52. PubMed ID: 24577455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropsychological correlates of whole brain atrophy in Alzheimer's disease.
    Schott JM; Crutch SJ; Frost C; Warrington EK; Rossor MN; Fox NC
    Neuropsychologia; 2008; 46(6):1732-7. PubMed ID: 18395233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diurnal fluctuations in brain volume: Statistical analyses of MRI from large populations.
    Nakamura K; Brown RA; Narayanan S; Collins DL; Arnold DL;
    Neuroimage; 2015 Sep; 118():126-32. PubMed ID: 26049148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease.
    Jack CR; Lowe VJ; Weigand SD; Wiste HJ; Senjem ML; Knopman DS; Shiung MM; Gunter JL; Boeve BF; Kemp BJ; Weiner M; Petersen RC;
    Brain; 2009 May; 132(Pt 5):1355-65. PubMed ID: 19339253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative.
    Carmichael O; Schwarz C; Drucker D; Fletcher E; Harvey D; Beckett L; Jack CR; Weiner M; DeCarli C;
    Arch Neurol; 2010 Nov; 67(11):1370-8. PubMed ID: 21060014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Harmonized benchmark labels of the hippocampus on magnetic resonance: the EADC-ADNI project.
    Bocchetta M; Boccardi M; Ganzola R; Apostolova LG; Preboske G; Wolf D; Ferrari C; Pasqualetti P; Robitaille N; Duchesne S; Jack CR; Frisoni GB;
    Alzheimers Dement; 2015 Feb; 11(2):151-60.e5. PubMed ID: 25223727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Retrospective Belgian Multi-Center MRI Biomarker Study in Alzheimer's Disease (REMEMBER).
    Niemantsverdriet E; Ribbens A; Bastin C; Benoit F; Bergmans B; Bier JC; Bladt R; Claes L; De Deyn PP; Deryck O; Hanseeuw B; Ivanoiu A; Lemper JC; Mormont E; Picard G; Salmon E; Segers K; Sieben A; Smeets D; Struyfs H; Thiery E; Tournoy J; Triau E; Vanbinst AM; Versijpt J; Bjerke M; Engelborghs S
    J Alzheimers Dis; 2018; 63(4):1509-1522. PubMed ID: 29782314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults.
    Risacher SL; McDonald BC; Tallman EF; West JD; Farlow MR; Unverzagt FW; Gao S; Boustani M; Crane PK; Petersen RC; Jack CR; Jagust WJ; Aisen PS; Weiner MW; Saykin AJ;
    JAMA Neurol; 2016 Jun; 73(6):721-32. PubMed ID: 27088965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving brain atrophy quantification with deep learning from automated labels using tissue similarity priors.
    Clèrigues A; Valverde S; Oliver A; Lladó X;
    Comput Biol Med; 2024 Sep; 179():108811. PubMed ID: 38991315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers.
    Schuff N; Woerner N; Boreta L; Kornfield T; Shaw LM; Trojanowski JQ; Thompson PM; Jack CR; Weiner MW;
    Brain; 2009 Apr; 132(Pt 4):1067-77. PubMed ID: 19251758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between executive dysfunction and hippocampal volume in Alzheimer's disease.
    Nagata T; Shinagawa S; Ochiai Y; Aoki R; Kasahara H; Nukariya K; Nakayama K
    Int Psychogeriatr; 2011 Jun; 23(5):764-71. PubMed ID: 21106135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular and Alzheimer's disease markers independently predict brain atrophy rate in Alzheimer's Disease Neuroimaging Initiative controls.
    Barnes J; Carmichael OT; Leung KK; Schwarz C; Ridgway GR; Bartlett JW; Malone IB; Schott JM; Rossor MN; Biessels GJ; DeCarli C; Fox NC;
    Neurobiol Aging; 2013 Aug; 34(8):1996-2002. PubMed ID: 23522844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.